BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34916040)

  • 1. The pathogeneses of pemphigus and pemphigoid diseases.
    Ujiie H; Yamagami J; Takahashi H; Izumi K; Iwata H; Wang G; Sawamura D; Amagai M; Zillikens D
    J Dermatol Sci; 2021 Dec; 104(3):154-163. PubMed ID: 34916040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune bullous dermatoses.
    Holtsche MM; Boch K; Schmidt E
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):405-412. PubMed ID: 37070500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition and bullous diseases.
    Stoj V; Lu J
    Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
    Kridin K; Hübner F; Linder R; Schmidt E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1826-1830. PubMed ID: 35611551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
    Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
    Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bullous autoimmune dermatoses of the mucous membranes].
    Didona D; Hinterseher J; Eming R
    Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bullous autoimmune diseases of the oral mucosa].
    Vaillant L
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
    Raap U; Limberg MM; Kridin K; Ludwig RJ
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern diagnostics of autoimmune bullous diseases].
    van Beek N; Schumacher N; Rose C; Schmidt E; Zillikens D
    Pathologe; 2020 Jul; 41(4):317-325. PubMed ID: 32542511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune bullous skin disorders].
    Hertl M; Niedermeier A; Borradori L
    Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of palms and soles in patients with autoimmune bullous diseases: a comparative analysis of a diagnostically relevant localization.
    Jałowska M; Spałek M; Bowszyc-Dmochowska M; Gornowicz-Porowska J; Dmochowski M
    Front Immunol; 2023; 14():1227855. PubMed ID: 37885886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches and targets for treatment of autoimmune bullous diseases.
    Bardazzi F; Loi C; Chessa Marco A; Di Altobrando A; Filippi F; Lacava R; Viviani F; Balestri R; Leuzzi M; Sacchelli L
    Dermatol Ther; 2021 Sep; 34(5):e15032. PubMed ID: 34145701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune bullous skin diseases, pemphigus and pemphigoid.
    Egami S; Yamagami J; Amagai M
    J Allergy Clin Immunol; 2020 Apr; 145(4):1031-1047. PubMed ID: 32272980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.